Overview

This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men

Status:
Completed
Trial end date:
2018-05-02
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to investigate the relative bioavailabilities of digoxin, furosemide, metformin and rosuvastatin given as a cocktail alone and as a cocktail together with the following drug transporter inhibitors: Part 1: verapamil (P-gp) and rifampin (OATP1B1/1B3) Part 2: cimetidine (OCT2/MATE) Part 3: probenecid (OAT1/3) The secondary objective is to investigate other potential changes in pharmacokinetics (e.g. in clearance, volume of distribution, etc.) of digoxin, furosemide, metformin and rosuvastatin given as a cocktail alone and as a cocktail together with the inhibitors describe above.
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Cimetidine
Digoxin
Furosemide
Metformin
Probenecid
Rifampin
Rosuvastatin Calcium
Verapamil